Agents for the molecular imaging of serine-protease in human pathologies
US9272054B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Jan 27, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/1024
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to the use of an irreversible ligand of a serine protease selected from the group consisting of leukocyte elastase, thrombin, tissue plasminogen activator (t-PA) and plasmin for the molecular imaging of said serine protease and the diagnosis of pathophysiological conditions associated with said serine protease activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.